FIELD: chemistry.
SUBSTANCE: invention concerns new compounds of formula I or their pharmaceutically acceptable salts: , where R1 is selected out of C3-10cycloalkyl-C1-6alkyl, tetrahydropyranyl-C1-6alkyl and tetrahydropyranyl, where the C3-10cycloalkyl-C1-6alkyl, tetrahydropyranyl -C1-6alkyl and tetrahydropyranyl used in definition of R1 are possibly substituted by one or more group selected out of halogen, methyl and ethyl; R2 is C1-10alkyl, where the C1-10alkyl used in definition of R2 is optionally substituted by one or more group selected out of methyl, ethyl; R3 is selected out of -H, C1-10alkyl, C2-10alkenyl, pyrrolidinyl, morpholinyl, piperidinyl, pyrrolidinyl-ethyl, morpholinyl-ethyl, piperidinyl-ethyl and
, possibly substituted by one or more group selected out of C1-6alkyl, amino, C1-6alkoxy; or R3 is 2-aminoethoxy-ethyl or (2-hydroxyethyl)amino-ethyl; each of R8 and R9 is C1-10alkyl; and R4 is selected out of -H and C1-10alkyl. Invention also concerns compounds selected out of the group, application of compounds for any of claim points 1-5, pharmaceutical composition, and method of obtaining compounds of the formula I.
EFFECT: obtaining new bioactive compounds with agonistic effect selective in respect of CB1 receptors.
11 cl, 12 ex
Title | Year | Author | Number |
---|---|---|---|
BENZIMIDAZOLE DERIVATIVES, COMPOSITIONS CONTAINING THEM, OBTAINING THEM AND THEIR USE | 2004 |
|
RU2329254C2 |
IMIDAZOPYRIDINE COMPOUNDS AS PAD INHIBITORS | 2018 |
|
RU2782743C2 |
HETEROCYCLIC COMPOUNDS AS PAD INHIBITORS | 2018 |
|
RU2764243C2 |
CATECHOL-O-METHYL TRANSFERASE INHIBITORS AND USE THEREOF IN TREATING PSYCHOTIC DISORDERS | 2011 |
|
RU2586974C2 |
SUBSTITUTED HETEROCYCLIC FUSED CYCLIC COMPOUND, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL USE THEREOF | 2020 |
|
RU2815814C1 |
NOCICEPTIN ANALOGUES | 2002 |
|
RU2426730C2 |
ISOINDOLINONE INHIBITORS OF MDM2-P53 INTERACTION WITH ANTI-CANCER ACTIVITY | 2016 |
|
RU2794333C1 |
DERIVATIVES OF BENZIMIDAZOLE AND PHARMACEUTICAL COMPOSITIONS BASED ON THEREOF | 2002 |
|
RU2265018C2 |
NUCLEOSIDE ARYL PHOSPHORAMIDATES AND USE THEREOF AS ANTI-VIRAL AGENTS FOR TREATING HEPATITUS C VIRUS | 2007 |
|
RU2464272C2 |
OESTROGEN RECEPTORS LIGANDS | 2012 |
|
RU2620375C9 |
Authors
Dates
2009-02-20—Published
2004-09-24—Filed